The differentiation and protective function of cytolytic CD4 T cells in influenza infection

Frontiers in Immunology

Volumn 7, Issue MAR, 2016, Pages

  Brown, Deborah M ^a,b   Lampe, Anna T ^a,b   Workman, Aspen M ^b,c  

^a UNIVERSITY OF NEBRASKA   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c U S MEAT ANIMAL RESEARCH CENTER   (United States)

Author keywords

CD4 cytolytic cells; CD4 effectors; Granzyme B; Influenza A virus; Perforin

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; HUMAN; IMMUNE RESPONSE; INFLUENZA; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VACCINATION;

EID: 84964645627     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00093     Document Type: Review

References (52)

1. Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4(+) T cells in immunity to viruses. Nat Rev Immunol (2012) 12:136-48. doi: 10.1038/nri3152.
2. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol (2010) 28:445-89. doi:10.1146/annurev-immunol-030409-101212.
3. Dennert G, Swain SL, Waterfield JD, Warner JF, Dutton RW. Fine specificity mapping of two allospecific T cell lines: recognition of private specificities in the H-2 IA subregion. Eur J Immunol (1981) 11:62-4. doi:10.1002/eji.1830110113.
4. Swain SL, Dennert G, Wormsley S, Dutton RW. The Lyt phenotype of a long-term allospecific T cell line. Both helper and killer activities to IA are mediated by Ly-1 cells. Eur J Immunol (1981) 11:175-80. doi:10.1002/eji.1830110304.
5. Lukacher AE, Morrison LA, Braciale VL, Malissen B, Braciale TJ. Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones. J Exp Med (1985) 162:171-87. doi:10.1084/jem.162.1.171.
6. Appay V. The physiological role of cytotoxic CD4(+) T-cells: the holy grail? Clin Exp Immunol (2004) 138:10-3. doi:10.1111/j.1365-2249.2004.02605.x.
7. Appay V, Zaunders JJ, Papagno L, Sutton J, Jaramillo A, Waters A, et al. Characterization of CD4(+) CTLs ex vivo. J Immunol (2002) 168:5954-8. doi:10.4049/jimmunol.168.11.5954.
8. Casazza JP, Betts MR, Price DA, Precopio ML, RuffLE, Brenchley JM, et al. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med (2006) 203:2865-77. doi:10.1084/jem.20052246.
9. Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, Pertel T, et al. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci Transl Med (2012) 4:123ra125. doi:10.1126/scitranslmed.3003165.
10. Soghoian DZ, Streeck H. Cytolytic CD4(+) T cells in viral immunity. Expert Rev Vaccines (2010) 9:1453-63. doi:10.1586/erv.10.132.
11. Heller KN, Gurer C, Munz C. Virus-specific CD4+ T cells: ready for direct attack. J Exp Med (2006) 203:805-8. doi:10.1084/jem.20060215.
12. Paludan C, Bickham K, Nikiforow S, Tsang ML, Goodman K, Hanekom WA, et al. Epstein-Barr nuclear antigen 1-specific CD4(+) Th1 cells kill Burkitt's lymphoma cells. J Immunol (2002) 169:1593-603. doi:10.4049/jimmunol.169.3.1593.
13. Jellison ER, Kim SK, Welsh RM. Cutting edge: MHC class II-restricted killing in vivo during viral infection. J Immunol (2005) 174:614-8. doi:10.4049/jimmunol.174.2.614.
14. Zajac AJ, Quinn DG, Cohen PL, Frelinger JA. Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection. Proc Natl Acad Sci U S A (1996) 93:14730-5. doi:10.1073/pnas.93.25.14730.
15. Stuller KA, Cush SS, Flano E. Persistent gamma-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations. J Immunol (2010) 184:3850-6. doi:10.4049/jimmunol.0902935.
16. Stuller KA, Flano E. CD4 T cells mediate killing during persistent gammaherpesvirus 68 infection. J Virol (2009) 83:4700-3. doi:10.1128/JVI.02240-08.
17. Fang M, Siciliano NA, Hersperger AR, Roscoe F, Hu A, Ma X, et al. Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection. Proc Natl Acad Sci U S A (2012) 109:9983-8. doi:10.1073/pnas.1202143109.
18. Verma S, Weiskopf D, Gupta A, McDonald B, Peters B, Sette A, et al. Cytomegalovirus-specific CD4 T cells are cytolytic and mediate vaccine protection. J Virol (2015) 90:650-8. doi:10.1128/JVI.02123-15.
19. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med (2012) 18:274-80. doi:10.1038/nm.2612.
20. Brown DM, Lee S, Garcia-Hernandez Mde L, Swain SL. Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection. J Virol (2012) 86:6792-803. doi:10.1128/JVI.07172-11.
21. Hua L, Yao S, Pham D, Jiang L, Wright J, Sawant D, et al. Cytokine-dependent induction of CD4+ T cells with cytotoxic potential during influenza virus infection. J Virol (2013) 87:11884-93. doi:10.1128/JVI.01461-13.
22. Workman AM, Jacobs AK, Vogel AJ, Condon S, Brown DM. Inflammation enhances IL-2 driven differentiation of cytolytic CD4 T cells. PLoS One (2014) 9:e89010. doi:10.1371/journal.pone.0089010.
23. Stalder T, Hahn S, Erb P. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol (1994) 152:1127-33.
24. Brown DM. Cytolytic CD4 cells: direct mediators in infectious disease and malignancy. Cell Immunol (2010) 262:89-95. doi:10.1016/j.cellimm.2010.02.008.
25. Graham MB, Braciale VL, Braciale TJ. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med (1994) 180:1273-82. doi:10.1084/jem.180.4.1273.
26. Brown DM, Dilzer AM, Meents DL, Swain SL. CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J Immunol (2006) 177:2888-98. doi:10.4049/jimmunol.177.5.2888.
27. Brown DM, Kamperschroer C, Dilzer AM, Roberts DM, Swain SL. IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells. Cell Immunol (2009) 257:69-79. doi:10.1016/j.cellimm.2009.03.002.
28. McKinstry KK, Strutt TM, Kuang Y, Brown DM, Sell S, Dutton RW, et al. Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. J Clin Invest (2012) 122:2847-56. doi:10.1172/JCI63689.
29. Teijaro JR, Verhoeven D, Page CA, Turner D, Farber DL. Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms. J Virol (2010) 84:9217-26. doi:10.1128/JVI.01069-10.
30. McKinstry KK, Dutton RW, Swain SL, Strutt TM. Memory CD4 T -cell-mediated immunity against influenza A virus: more than a little helpful. Arch Immunol Ther Exp (Warsz) (2013) 61:341-53. doi:10.1007/s00005-013-0236-z.
31. Hildemann SK, Eberlein J, Davenport B, Nguyen TT, Victorino F, Homann D. High efficiency of antiviral CD4(+) killer T cells. PLoS One (2013) 8:e60420. doi:10.1371/journal.pone.0060420.
32. Brennan AJ, House IG, Oliaro J, Ramsbottom KM, Hagn M, Yagita H, et al. A method for detecting intracellular perforin in mouse lymphocytes. J Immunol (2014) 193:5744-50. doi:10.4049/jimmunol.1402207.
33. Pipkin ME, Rao A, Lichtenheld MG. The transcriptional control of the perforin locus. Immunol Rev (2010) 235:55-72. doi:10.1111/j.0105-2896.2010.00905.x.
34. Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, Bevan MJ, Rao A. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity (2010) 32:79-90. doi:10.1016/j.immuni.2009.11.012.
35. Lin L, Couturier J, Yu X, Medina MA, Kozinetz CA, Lewis DE. Granzyme B secretion by human memory CD4 T cells is less strictly regulated compared to memory CD8 T cells. BMC Immunol (2014) 15:36. doi:10.1186/s12865-014-0036-1.
36. McElhaney JE, Ewen C, Zhou X, Kane KP, Xie D, Hager WD, et al. Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine (2009) 27:2418-25. doi:10.1016/j.vaccine.2009.01.136.
37. Zhou X, McElhaney JE. Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine (2011) 29:2169-77. doi:10.1016/j.vaccine.2010.12.029.
38. Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med (2013) 19:1305-12. doi:10.1038/nm.3350.
39. Takeuchi A, Badr ME, Miyauchi K, Ishihara C, Onishi R, Guo Z, et al. CRTAM determines the CD4+ cytotoxic T lymphocyte lineage. J Exp Med (2015) 213: 123-38. doi:10.1084/jem.20150519.
40. Brown DM, Workman AM, Vogel AJ, Condon S. Inflammation regulates the differentiation of CD4 T cells with cytolytic potential. J Immunol (2013) 190:173.171.
41. Kaech SM, Cui W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol (2012) 12:749-61. doi:10.1038/nri3307.
42. Qui HZ, Hagymasi AT, Bandyopadhyay S, St Rose MC, Ramanarasimhaiah R, Menoret A, et al. CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation. J Immunol (2011) 187:3555-64. doi:10.4049/jimmunol.1101244.
43. Curran MA, Geiger TL, Montalvo W, Kim M, Reiner SL, Al-Shamkhani A, et al. Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin. J Exp Med (2013) 210:743-55. doi:10.1084/jem.20121190.
44. Hirschhorn-Cymerman D, Budhu S, Kitano S, Liu C, Zhao F, Zhong H, et al. Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype. J Exp Med (2012) 209:2113-26. doi:10.1084/jem.20120532.
45. Vogel AJ, Brown DM. Single-dose CpG immunization protects against a heterosubtypic challenge and generates antigen-specific memory T cells. Front Immunol (2015) 6:327. doi:10.3389/fimmu.2015.00327.
46. Strutt TM, McKinstry KK, Kuang Y, Bradley LM, Swain SL. Memory CD4+ T-cell-mediated protection depends on secondary effectors that are distinct from and superior to primary effectors. Proc Natl Acad Sci U S A (2012) 109:E2551-60. doi:10.1073/pnas.1205894109.
47. Moore TC, Vogel AJ, Petro TM, Brown DM. IRF3 deficiency impacts granzyme B expression and maintenance of memory T cell function in response to viral infection. Microbes Infect (2015) 17:426-39. doi:10.1016/j.micinf.2015.03.001.
48. Graham CM, Christensen JR, Thomas DB. Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma? Immunology (2007) 121:238-47. doi:10.1111/j.1365-2567.2007.02563.x.
49. Strutt TM, McKinstry KK, Marshall NB, Vong AM, Dutton RW, Swain SL. Multipronged CD4(+) T-cell effector and memory responses cooperate to provide potent immunity against respiratory virus. Immunol Rev (2013) 255:149-64. doi:10.1111/imr.12088.
50. Coler RN, Hudson T, Hughes S, Huang PW, Beebe EA, Orr MT. Vaccination produces CD4 T cells with a novel CD154-CD40-dependent cytolytic mechanism. J Immunol (2015) 195:3190-7. doi:10.4049/jimmunol.1501118.
51. McElhaney JE, Coler RN, Baldwin SL. Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults. Expert Rev Vaccines (2013) 12:759-66. doi:10.1586/14760584.2013.811193.
52. Haq K, McElhaney JE. Immunosenescence: influenza vaccination and the elderly. Curr Opin Immunol (2014) 29:38-42. doi:10.1016/j.coi.2014.03.008.